PUFF BAR to Launch PUFF Max in Korean Market

Aug.08.2022
PUFF BAR to Launch PUFF Max in Korean Market
US e-cigarette brand PUFF BAR plans to launch PUFF Max in South Korea, targeting consumers with 12 different flavors.

The American e-cigarette brand, PUFF BAR, has announced that they will be launching PUFF Max in approximately one week, officially entering the South Korean market.


Although there are already many high-capacity disposable electronic cigarette products available in South Korea, the successful American brand PUFF Max plans to target Korean consumers with a differentiated product lineup.


The PUFF Max disposable e-cigarette comes in 12 different flavors. PUFF Max, the brand's flagship product, made its debut with 3000 puffs and outstanding performance, achieving high sales in the disposable e-cigarette market in the US and globally.


According to the marketing manager of Puff Korea Co., Ltd., "Starting with our first product, PUFF Max, we will launch five new American products and 30 flavors in the Korean market this year to quickly gain market share." He stated that PUFF Max, which debuted in Korea, is "a product that can be easily used anytime, anywhere," and Puff Korea plans to lead the global electronic cigarette market by entering the fiercely competitive Korean market with the slogan "Get the new sweet color now! Taste it! Live it!" The company also plans to continuously develop and release patented products equipped with new technologies.


Puff Korea, a subsidiary of PUFF BAR, announced plans to invest in a new production line and product releases in Korea to prepare for global exports. The initial facilities investment is expected to be around KRW 30 billion, with plans to add KRW 500 billion in business in the future.


Statement:


This article is compiled from third-party information and is intended for industry professionals for the purpose of educational exchange.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the truthfulness and accuracy of the article's content. The compilation of this article is solely for industry-related communication and research.


Due to limitations in our translation ability, the translated article may not fully reflect the original meaning. Please refer to the original article for accuracy.


2FIRSTS maintains complete consistency with the Chinese government in regards to any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.


The copyright of compiled information belongs to the original media and authors, and if there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

NACS Urges USTR to Address Illegal E-Cigarette Exports in China Trade Engagements
NACS Urges USTR to Address Illegal E-Cigarette Exports in China Trade Engagements
NACS submitted a comment letter to USTR in a proceeding examining unfair trade practices worldwide. The letter focuses on illicit nicotine products made in China and shipped to the United States in violation of U.S. law. NACS said the U.S. electronic nicotine delivery systems market has become dominated by illicit products, mainly disposable e-cigarettes manufactured in China and sold without the marketing authorization required by the U.S. Food and Drug Administration.
Apr.16 by 2FIRSTS.ai
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”
U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”
At a policy forum hosted by The Hill and sponsored by PMI US, U.S. defense health officials, lawmakers and industry representatives discussed tobacco use in the military and explored the potential role of smoke-free nicotine products — including e-cigarettes and nicotine pouches — as transitional tools to help service members reduce reliance on combustible cigarettes.
PMI
Mar.23
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
The U.S. Food and Drug Administration announced on May 6 that it has advanced its modernization initiative by launching Elsa 4.0, an upgraded internal AI tool, and consolidating more than 40 application and submission data sources, systems and portals into a new platform called HALO. FDA said the integration of HALO and Elsa will allow staff to query data and build workflows without manually uploading documents in each chat.
May.07 by 2FIRSTS.ai
FDA nicotine pouch review delay report knocks tobacco shares lower
FDA nicotine pouch review delay report knocks tobacco shares lower
After Reuters reported before the market open that FDA reviews of nicotine pouch applications could face delays, shares of Philip Morris International, Turning Point Brands and British American Tobacco fell on April 1, underscoring the direct impact of U.S. regulatory signals on major tobacco companies and nicotine pouch expectations.
Apr.02
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12